 Immunoblotting
"Immunoblotting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies.
| Descriptor ID |
D015151
|
| MeSH Number(s) |
E05.478.566.320 E05.601.470.320
|
| Concept/Terms |
Immunoblotting, Reverse- Immunoblotting, Reverse
- Immunoblottings, Reverse
- Reverse Immunoblottings
- Reverse Immunoblotting
Immunoelectroblotting- Immunoelectroblotting
- Immunoelectroblottings
- Electroimmunoblotting
- Electroimmunoblottings
Dot Immunoblotting- Dot Immunoblotting
- Immunoblotting, Dot
- Dot Immunoblottings
- Immunoblottings, Dot
|
Below are MeSH descriptors whose meaning is more general than "Immunoblotting".
Below are MeSH descriptors whose meaning is more specific than "Immunoblotting".
This graph shows the total number of publications written about "Immunoblotting" by people in this website by year, and whether "Immunoblotting" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 | | 1996 | 0 | 6 | 6 | | 1997 | 0 | 4 | 4 | | 1998 | 0 | 4 | 4 | | 1999 | 0 | 4 | 4 | | 2000 | 0 | 2 | 2 | | 2001 | 0 | 8 | 8 | | 2002 | 0 | 7 | 7 | | 2003 | 0 | 9 | 9 | | 2004 | 0 | 12 | 12 | | 2005 | 0 | 16 | 16 | | 2006 | 0 | 2 | 2 | | 2007 | 0 | 4 | 4 | | 2008 | 1 | 7 | 8 | | 2009 | 0 | 14 | 14 | | 2010 | 1 | 18 | 19 | | 2011 | 0 | 10 | 10 | | 2012 | 0 | 4 | 4 | | 2013 | 0 | 9 | 9 | | 2014 | 0 | 11 | 11 | | 2015 | 0 | 12 | 12 | | 2016 | 0 | 8 | 8 | | 2017 | 0 | 5 | 5 | | 2018 | 0 | 1 | 1 | | 2019 | 0 | 2 | 2 | | 2020 | 0 | 1 | 1 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoblotting" by people in Profiles.
-
Brock EJ, Jackson RM, Boerner JL, Li Q, Tennis MA, Sloane BF, Mattingly RR. Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma. PLoS One. 2021; 16(5):e0252314.
-
Galant-Swafford J, Zuraw BL, Herschbach J, Mahata M, Mockford EL, Christiansen SC. What is in your pantry? Entomologic anaphylaxis. Allergy Asthma Proc. 2020 07 01; 41(4):290-295.
-
Mishra AK, Kumar A, Yadav S, Anand M, Yadav B, Nigam R, Garg SK, Swain DK. Functional insights into voltage gated proton channel (Hv1) in bull spermatozoa. Theriogenology. 2019 Sep 15; 136:118-130.
-
Shea D, Hsu CC, Bi TM, Paranjapye N, Childers MC, Cochran J, Tomberlin CP, Wang L, Paris D, Zonderman J, Varani G, Link CD, Mullan M, Daggett V. a-Sheet secondary structure in amyloid ?-peptide drives aggregation and toxicity in Alzheimer's disease. Proc Natl Acad Sci U S A. 2019 04 30; 116(18):8895-8900.
-
Kiseljak-Vassiliades K, Zhang Y, Kar A, Razzaghi R, Xu M, Gowan K, Raeburn CD, Albuja-Cruz M, Jones KL, Somerset H, Fishbein L, Leong S, Wierman ME. Elucidating the Role of the Maternal Embryonic Leucine Zipper Kinase in Adrenocortical Carcinoma. Endocrinology. 2018 07 01; 159(7):2532-2544.
-
Kar A, Liu B, Gutierrez-Hartmann A. ESE-1 Knockdown Attenuates Growth in Trastuzumab-resistant HER2+ Breast Cancer Cells. Anticancer Res. 2017 12; 37(12):6583-6591.
-
Tseytin I, Dagan A, Oren S, Sal-Man N. The role of EscD in supporting EscC polymerization in the type III secretion system of enteropathogenic Escherichia coli. Biochim Biophys Acta Biomembr. 2018 Feb; 1860(2):384-395.
-
Kumar R, Deep G, Wempe MF, Surek J, Kumar A, Agarwal R, Agarwal C. Procyanidin B2 3,3?-di-O-gallate induces oxidative stress-mediated cell death in prostate cancer cells via inhibiting MAP kinase phosphatase activity and activating ERK1/2 and AMPK. Mol Carcinog. 2018 Jan; 57(1):57-69.
-
Bonney S, Siegenthaler JA. Differential Effects of Retinoic Acid Concentrations in Regulating Blood-Brain Barrier Properties. eNeuro. 2017 May-Jun; 4(3).
-
Ohm AM, Tan AC, Heasley LE, Reyland ME. Co-dependency of PKCd and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer. Oncogene. 2017 07 27; 36(30):4370-4378.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|